Industry & Business

Diaceutics Raises €4.3 Million to Support Global Expansion

 Breaking News
  • OPW Prepared For No Deal Brexit “If there is a ‘crash-out’, we will be ready. We are working 24/7,” said Maurice Buckley (pictured), Chairman of the Office of Public Works (OPW) and Vice President of Engineers Ireland, about preparations for installing infrastructure at ports and airports in the event of a ‘no deal Brexit’. “Eighteen separate construction projects are now underway [...]...
  • Irish Builders Face Cost Hikes in UK Materials The vast majority of building materials used in the Irish construction sector are either sourced in the UK or enter Ireland through international distributors in Britain and represent a major risk for the industry, according to executives at the recent National Construction Summit in Citywest, Dublin – writes John Whelan (pictured above). And a huge majority of [...]...
  • Marketing Campaign Worth €1.2 Million Unveiled by Guaranteed Irish Guaranteed Irish, the not-for-profit business membership organisation championing 600+ homegrown and international businesses in Ireland, has unveiled a new marketing campaign worth €1.2 million, aimed at showcasing its members’ success. The campaign has been launched to coincide with Guaranteed Irish Month, an annual event running throughout March that shines a spotlight on businesses in Ireland [...]...
  • Jameson Enters the Top 10 Premium Spirits Brands in the World List Jameson Irish whiskey, which is produced by Irish Distillers at Midleton Distillery in Cork, has entered the top 10 of IMPACT magazine’s annual ‘Top 100 Premium Spirits Brands Worldwide’ list for the first time ever, after increasing sales 10% to a record 7.5 million nine-litre cases in 2018. In addition, Jameson scored its 18th consecutive year [...]...
  • Growth in Demand For Waste Handling Equipment Expected Sales of waste handling and processing equipment are conservatively expected to increase by 5% to 10% annually in unit terms over the next decade, and possibly beyond, according to a study being conducted by leading Birdhill and Rathcoole-based plant and equipment distributor, McHale Plant Sales. Conscious of the growing importance of waste management, and of the [...]...

Diaceutics Raises €4.3 Million to Support Global Expansion

Diaceutics Raises €4.3 Million to Support Global Expansion
April 09
11:53 2018

Irish company, Diaceutics, the diagnostic commercialisation company that improves patient outcomes via better diagnostic testing, has raised €4.3 million in new mezzanine financing from two partners, WhiteRock Capital Partners and Silicon Valley Bank. The money will be used to support the organisation’s continued global expansion.

Specifically, Diaceutics will use the funding to invest in the data analytics services that it provides to pharmaceutical clients and continue to expand its global laboratory network. The company will also look to grow the internal team of experts to deliver data-driven insights designed to improve diagnostic testing that benefits patients.

A recent analysis of Diaceutics testing data revealed that, globally, over 150,000 cancer patients are missing out on potentially life-saving therapies due to substandard diagnostic testing. By investing in expanding their data sources, and continuing to build expertise in oncology and general medicine disease areas, Diaceutics will further enable pharmaceutical clients to more effectively commercialise targeted medications. The results will deliver enhanced diagnostics and more effective treatment for patients.

Over the last three years, the company has experienced revenue growth of 60% year-on-year. In 2017, it achieved revenue of $10 million and aims to reach $40 million revenue by the end of 2020. Moreover, the organisation currently works with 31 out of the world’s top 35 pharmaceutical companies. It recently, announced a partnership with Intel and Lenovo to leverage artificial intelligence in a machine learning environment to further improve the diagnosis and treatment of patients.

By working with WhiteRock Capital Partners, which works with businesses with export potential, and Silicon Valley Bank, which enables companies across the areas of technology, healthcare and data to access emerging markets across the globe, Diaceutics will continue its accelerated growth path and increase its international reach.

Speaking about the new partnerships, Peter Keeling, CEO, Diaceutics, said: “Our focus has always been, and will continue to be, helping patients benefit from better testing. Silicon Valley Bank and WhiteRock Capital Partners have been hugely supportive of this vision and we are delighted to have them as partners at the table.

“We need to continually broaden our global data capabilities and insights; this mezzanine financing allows us to keep pace with our data collection and protection infrastructure while expanding globally. Furthermore, we are eager to continue diversifying beyond our expertise in oncology into general medicine areas, and provide our pharmaceutical clients with invaluable insights that help them ensure patients who can benefit from these precision drugs are indeed receiving them.”

Andrew Gowdy, Senior Portfolio Manager, WhiteRock Capital Partners, commented: “Diaceutics is paving the way when it comes to precision medicine, transforming how patients are diagnosed and treated. Partnering with a company that is revolutionising healthcare and expanding at an incredible rate is very exciting.”

These sentiments were echoed by Clive Lennox, Director of Irish Business Development, Silicon Valley Bank, who said: “Our aim is to work with innovators who are solving real world problems and Diaceutics certainly delivers those solutions. We’re committed to supporting the burgeoning Irish technology market and we are thrilled to be involved with such a dynamic organisation, as it takes the next step in its journey and expands out into a wider range of markets.”

CAPTION:

Pictured at the announcement are (L-R): Andrew Gowdy, Senior Portfolio Manager, WhiteRock Capital Partners; Peter Keeling, CEO, Diaceutics; and Clive Lennox, Director of Irish Business Development, Silicon Valley Bank. Mandatory Credit ©Press Eye/Darren Kidd

About Author

admin

admin

Related Articles

New Subscriber

Subscribe Here



Advertisements





















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4